Healthcare Solutions

Readmission Risk Intelligence

Case managers and discharge planners lack real-time risk stratification tools that combine LACE score components with diagnosis cohort data and post-acute care utilization patterns to identify patients at high risk of 30-day readmission before discharge. CMS penalized over 2,500 hospitals in 2023 for excess readmissions under the Hospital Readmissions Reduction Program (HRRP), with penalties reaching 3% of base Medicare reimbursements. Retrospective quality reports surface readmission patterns weeks after the care gap was actionable.

Built For

Quality Director reducing CMS HRRP penalties by improving discharge planning and post-acute care coordination across heart failure, pneumonia, and COPD cohorts

Deploy Your Virtual Workforce

Don't build from scratch. Deploy a pre-trained specialist agent instantly.

Ready

Lumi Care

Quality Director

Stratifies inpatient census by 30-day readmission risk using LACE components and diagnosis cohort data.

LACE Score Analysis
Risk Stratification
Diagnosis Cohort Analysis
Care Gap Identification
View Agent
Ready

Lumi Flow

Care Transitions Manager

Optimizes discharge disposition planning and post-acute care referral patterns to reduce readmission risk.

Discharge Planning Optimization
Post-Acute Referral Analysis
Transition of Care Tracking
View Agent
Ready

Lumi Watch

Compliance Analyst

Tracks HRRP performance and models CMS penalty exposure across readmission cohorts.

HRRP Performance Tracking
Penalty Exposure Modeling
CMS Reporting
View Agent

How It Works

Analyze 30-day readmission patterns using LACE score components, diagnosis cohorts, and discharge disposition data. Identify care gaps and high-risk patient segments before discharge.

Instant Analysis

Drag and drop your CSVs. No complex pipelines required.

Natural Language

Ask questions in plain English, get instant answers.

Lumina Analyst
Which patients on the census are highest risk for 30-day readmission and what gaps are driving it?

The heart-failure cohort is running an 18.6% 30-day readmission rate against the 15.1% HRRP peer benchmark, and 22 current inpatients carry a LACE score of 11 or higher, driven mainly by short length of stay and prior 6-month ED utilization. Recommend a pharmacist-led discharge follow-up and 48-hour callback for that group; it targets the gap before the next CMS measurement period locks in penalty exposure near 0.8% of Medicare base.

30-Day Readmission Rate vs HRRP Benchmark by Cohort
Ask a follow-up...